Keebeck Wealth Management

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1803675 Chicago, IL

Position in RLMD

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$90,480

New position

Shares Held

13,000

first reported quarter

Ownership

0.012%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Keebeck Wealth Management holds $1,033,322 across 3 Biotechnology names. RLMD ranks #3 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	25,176	$623,357
2	ADMA	Adma Biologics, Inc.	35,459	$319,485
3	RLMD	Relmada Therapeutics, Inc. This page	13,000	$90,480

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$90,480	13,000	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.